Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: JAMA Oncol. 2016 Apr 1;2(4):508–516. doi: 10.1001/jamaoncol.2015.4935

Figure 2.

Figure 2

A. Overall Survival by pathologic response to PST in axilla and breast.

Overall survival in patients stratified by response to PST in the axilla and the breast. pCR in both the axilla and breast is in green, pCR in the axilla but residual disease in the breast is in red, residual disease in the axilla but pCR in the breast is in blue, and residual disease in both the breast and axilla is in black. The number of patients at risk is indicated under the x-axis.

B. Relapse Free Survival by pathologic response to PST in axilla and breast.

Relapse-free survival in patients stratified by response to PST in the axilla and the breast. pCR in both the axilla and breast is in green, pCR in the axilla but residual disease in the breast is in red, residual disease in the axilla but pCR in the breast is in blue, and residual disease in both the breast and axilla is in black. The number of patients at risk is indicated under the x-axis.